December 19, 2017
UC San Francisco physician-scientists have developed a test that can predict how patients with juvenile myelomonocytic leukemia (JMML) will respond to treatment, and may also be able to identify patients who are likely to recover spontaneously with little to no treatment. The researchers are ...
December 15, 2017
For the third consecutive year, UC San Francisco is co-sponsoring the Precision Medicine World Conference (PMWC) in January 2018 to share the latest in the rapidly evolving space.
Renamed from the Personalized Medicine World Conference, the annual forum attracts more than 1,000 recognized authorities and experts to ...
December 13, 2017
2017 has been a year of collaboration, innovation, and achievement at the Helen Diller Family Comprehensive Cancer. As the year winds down, we take a moment to reflect on some highlights. Our dedicated clinicians, curious researchers, and inspired philanthropists joined forces with patients and families, ...
December 11, 2017
A new collaboration between the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC) and the biotechnology company Strata Oncology to provide free genomic testing to men with advanced prostate cancer could help patients nationwide gain access to cutting-edge treatment and lead to new therapies for ...
December 4, 2017
Children with an extremely deadly form of brain cancer might benefit from a new treatment that aims to direct an immune response against a mutant form of a protein found exclusively on cancer cells, according to a new study led by UC San Francisco researchers.
December 3, 2017
Peter Walter, PhD, professor of biochemistry and biophysics at UC San Francisco, has been named winner of a 2018 Breakthrough Prize in Life Sciences, for his research on a biological mechanism that normally protects cells, but can cause disease if not functioning properly.
November 21, 2017
The sugar industry buried scientific research almost 50 years ago that pointed to negative health effects of sugar, ceasing funding the research when it reflected negatively on the industry's interests, according to a new UC San Francisco study.
November 16, 2017
In September, Katherine Van Loon, MD, MPH, assistant professor in hematology/oncology and director of the HDFCCC Global Cancer Program, led a group of UCSF faculty and trainees to Tanzania to meet with stakeholders at the Muhimbili University of Health and Allied Sciences (MUHAS) and Ocean Road ...
November 15, 2017
Researchers believe mapping the connections between genes and proteins in many human cell types could hold the answers to understanding diseases from tuberculosis to cancer to autism.
November 6, 2017
The National Institute on Minority Health and Health Disparities (NIMHD) has appointed Anna Maria Nápoles, PhD, MPH, as scientific director of its Division of Intramural Research. Nápoles, a UC San Francisco behavioral epidemiologist, is the first Latina to be named a scientific director at the National Institutes of Health.